Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Endometrioid Adenocarcinoma

Explore clinical trials studying Fallopian Tube Endometrioid Adenocarcinoma. Study availability and eligibility vary by location and protocol.

22 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Endometrioid Adenocarcinoma trial results

Active, Not Recruiting

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00565851

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 709 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

NCT05276973

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +32 more
Locations
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details

Related conditions